|
CDC14B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.43469999506152E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0394000044277E-08 |
| Normal-vs-Stage2 |
9.999800E-03 |
| Normal-vs-Stage3 |
6.024900E-03 |
| Normal-vs-Stage4 |
2.646200E-02 |
| Stage1-vs-Stage2 |
5.761200E-01 |
| Stage1-vs-Stage3 |
9.835400E-01 |
| Stage1-vs-Stage4 |
8.754800E-01 |
| Stage2-vs-Stage3 |
6.746400E-01 |
| Stage2-vs-Stage4 |
6.001600E-01 |
| Stage3-vs-Stage4 |
9.147800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.83499995385506E-09 |
| Normal-vs-AfricanAmerican |
1.804350E-04 |
| Normal-vs-Asian |
5.280400E-02 |
| Caucasian-vs-AfricanAmerican |
5.928000E-01 |
| Caucasian-vs-Asian |
5.225400E-01 |
| AfricanAmerican-vs-Asian |
4.226200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.78370004614237E-09 |
| Normal-vs-Female |
7.88800000000034E-05 |
| Male-vs-Female |
6.628000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.02330000029127E-08 |
| Normal-vs-Extreme_Weight |
3.23909998822813E-09 |
| Normal-vs-Obese |
3.761000E-04 |
| Normal-vs-Extreme_Obese |
1.607690E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.857400E-01 |
| Normal_Weight-vs-Obese |
3.876200E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.084800E-01 |
| Extreme_Weight-vs-Obese |
1.206250E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.603600E-01 |
| Obese-vs-Extreme_Obese |
6.176800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.17219999999463E-05 |
| Normal-vs-Age(41-60Yrs) |
1.810540E-04 |
| Normal-vs-Age(61-80Yrs) |
3.12220027609555E-10 |
| Normal-vs-Age(81-100Yrs) |
2.677600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.678210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.655000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.663400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.725760E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.521600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.542800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.85209999956382E-07 |
| Normal-VS-Type2 PRCC |
7.13250000172749E-08 |
| Normal-VS-KIRP CIMP |
4.218400E-03 |
| Normal-VS-Unclassified PRCC |
5.764000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.990400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.862200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.828200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.707600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.210230E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.732400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.46650000038196E-07 |
| Normal-vs-N1 |
8.079900E-02 |
| Normal-vs-N2 |
1.9392399999929E-05 |
| N0-vs-N1 |
1.544650E-01 |
| N0-vs-N2 |
5.053000E-01 |
| N1-vs-N2 |
2.747600E-01 |
|
|
